AVEO Oncology (NASDAQ:AVEO) today announced poster presentations for two
Phase 2 clinical studies of tivozanib, one in metastatic colorectal
cancer (mCRC) and one in renal cell carcinoma (RCC), at the 2014
Congress of the European Society for Medical Oncology (ESMO), taking
place September 25–30 in Madrid, Spain.
By Russ Britt, MarketWatch
LOS ANGELES (MarketWatch)--The U.S. Supreme Court will rule on a new challenge to the Affordable Care Act to determine whether subsidies offered through federal exchanges are allowed under the law, a decision that could gut President Barack Obama's signature health-insurance initiative.
Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced that new data from clinical studies of the company’s
investigational, oral, once-daily, fixed-dose combination chronic
hepatitis C treatment grazoprevir/elbasvir (MK-5172/MK-8742) are
scheduled to be presented at the 65 th American Association
for the Study of Liver Diseases (AASLD) Annual Meeting, also known as
The Liver Meeting ® .
Sign-up for Merck to Present New Data from Clinical Studies Evaluating Investigational Hepatitis C Treatment Grazoprevir/Elbasvir (MK-5172/MK-8742) at the 65th American Association for the Study of Liver Diseases Annual Meeting investment picks
(NASDAQ: AMZN)—Amazon today announced the first six episodes of its
first original live-action kids series aimed at children aged 6 through
11, Gortimer Gibbon’s Life on Normal Street , are now available on
Prime Instant Video in the US.
CHICAGO and BANGALORE, India , November 11, 2014 /PRNewswire/ --
Infosys, a leader in consulting, technology, outsourcing and next generation services, announced today that it has successfully implemented its Finacle™ core banking solution for Discover Financial Services (NYSE: DFS) , a leading U.S. direct bank and payment services company.
Today, Columbia Seligman Premium Technology Growth Fund, Inc. (NYSE:
STK) (the Fund) declared a fourth-quarter distribution, pursuant to its
managed distribution policy, in the amount of $0.4625 per share, which
is equal to a quarterly rate of 2.3125% (9.25% annualized) of the $20.00
offering price in the Fund’s initial public offering in November 2009.
FORT LAUDERDALE, FL--(Marketwired - October 29, 2014) - JetBlue Airways (NASDAQ: JBLU) today expands its destination offerings at Fort Lauderdale-Hollywood International Airport (FLL) with the addition of four new routes.
By Sue Chang, MarketWatch
SAN FRANCISCO (MarketWatch) -- Among the companies whose shares are expected to see active trade in Wednesday's session are Bank of America Corp., Charles Schwab Corp., and St.
Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA) a research and
development-focused biotechnology company dedicated to creating small
molecule drugs primarily in the infectious disease field, today
announced that the European Committee for Medicinal Products for Human
Use (CHMP) of the European Medicines Agency (EMA) has granted positive
opinions for AbbVie’s investigational, all-oral, interferon-free
treatment of VIEKIRAX™ (a combination of ombitasvir, paritaprevir
(ABT-450) and ritonavir) plus EXVIERA™ (dasabuvir), with or without
ribavirin (RBV), for patients with genotype 1 (GT1) chronic hepatitis C
virus (HCV) infection, and VIEKIRAX™ only, with RBV, for patients with
genotype 4 (GT4) HCV infection.
Sign-up for Enanta Announces CHMP Grants Positive Opinions of AbbVie’s VIEKIRAX™ (ombitasvir/paritaprevir(ABT-450)/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe investment picks
Bank of America’s Global Wealth and Investment Management (GWIM)
division today announced that it has signed the United Nations-supported
Principles for Responsible Investment (PRI) on behalf of its
discretionary asset management businesses.
CONCORD, CA --
First Ebola Vaccine Candidate based on the 2014 Guinea Ebola Strain Genetic Sequence Robust immune responses demonstrated in preclinical studies; exceptional responses when used with Novavax' Matrix-M™ adjuvant Non-human primate study initiated GMP manufacture initiated; Scaled-up manufacturing to begin 1 st quarter 2015 Phase 1 clinical trial anticipated to start in December 2014
GAITHERSBURG, Md., Oct.
By Prudence Ho And Yvonne Lee
HONG KONG--China's largest nuclear firm has secured at least 15 cornerstone investors, including Singapore's sovereign-wealth fund, to take up around 40% of its US$3 billion Hong Kong initial public offering next month.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.